0023-1145-01 |
0023-1145 |
HUMAN PRESCRIPTION DRUG |
BOTOX |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRADERMAL; INTRAMUSCULAR |
19891215 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
100 [USP'U]/1 |
1 VIAL in 1 CARTON (0023-1145-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
0023-1145-02 |
0023-1145 |
HUMAN PRESCRIPTION DRUG |
BOTOX |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRADERMAL; INTRAMUSCULAR |
19891215 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
100 [USP'U]/1 |
1 VIAL in 1 CARTON (0023-1145-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
0023-9232-01 |
0023-9232 |
HUMAN PRESCRIPTION DRUG |
BOTOX Cosmetic |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAMUSCULAR |
20080520 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
100 [USP'U]/1 |
1 VIAL, GLASS in 1 CARTON (0023-9232-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
0023-9232-02 |
0023-9232 |
HUMAN PRESCRIPTION DRUG |
BOTOX Cosmetic |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAMUSCULAR |
20080520 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
100 [USP'U]/1 |
1 VIAL, GLASS in 1 CARTON (0023-9232-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
0023-3919-50 |
0023-3919 |
HUMAN PRESCRIPTION DRUG |
BOTOX Cosmetic |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAMUSCULAR |
20080715 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
50 [USP'U]/1 |
1 VIAL, GLASS in 1 CARTON (0023-3919-50) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
0023-3919-51 |
0023-3919 |
HUMAN PRESCRIPTION DRUG |
BOTOX Cosmetic |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAMUSCULAR |
20080715 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
50 [USP'U]/1 |
1 VIAL, GLASS in 1 CARTON (0023-3919-51) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
0023-3921-02 |
0023-3921 |
HUMAN PRESCRIPTION DRUG |
BOTOX |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRADERMAL; INTRAMUSCULAR |
20100111 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
200 [USP'U]/1 |
1 VIAL in 1 CARTON (0023-3921-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
0023-3921-03 |
0023-3921 |
HUMAN PRESCRIPTION DRUG |
BOTOX |
onabotulinumtoxinA |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRADERMAL; INTRAMUSCULAR |
20100111 |
N/A |
BLA |
BLA103000 |
Allergan, Inc. |
BOTULINUM TOXIN TYPE A |
200 [USP'U]/1 |
1 VIAL in 1 CARTON (0023-3921-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |